Gnrh

Verify with FDA CVM →

19 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
1
Deaths Reported
530.0%
Death Rate

Active Ingredients

Gnrh

Administration Routes

UnknownIntramuscular

Species Affected

Cattle 19

Most Affected Breeds

Mixed (Cattle) 6
Aberdeen Angus 4
Cattle (other) 3
Cattle (unspecified) 2
Limousin 1
Simmental 1
Hereford cattle 1
Belted Galloway 1

Most Reported Reactions

Lack of efficacy - NOS 12
INEFFECTIVE, ESTRUS SYNCHRONIZ 6
Rectal prolapse 2
Infertility NOS 1
Unexplained death 1
Injection site gaseous gangrene 1
Injection site oedema 1
PR-LUNG(S), LESION(S) 1
Cutaneous emphysema 1
Application site abscess 1
Lateral recumbency 1
Collapse NOS (see also 'Cardio-vascular' and 'Neurological disorders') 1

Outcome Breakdown

Outcome Unknown
15 (78.9%)
Recovered/Normal
3 (15.8%)
Died
1 (5.3%)

Data Summary

Metric Value
Total adverse event reports 19
Reports involving death 1
Case-fatality rate (reported events) 530.0%
Distinct species in reports 1
Distinct breeds in reports 8
Distinct reactions reported 15
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Gnrh Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 19 adverse event reports referencing Gnrh, including 1 reports in which the animal died — a 530.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Gnrh. Reported administration routes include Unknown, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Gnrh reports are Cattle (19 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (6), Aberdeen Angus (4), Cattle (other) (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Gnrh are Lack of efficacy - NOS (12), INEFFECTIVE, ESTRUS SYNCHRONIZ (6), Rectal prolapse (2), Infertility NOS (1). Of the 19 reports with a coded outcome, Outcome Unknown is the leading category at 78.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Gnrh.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial